Foghorn Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

포그혼 테라퓨틱스NASDAQ:FHTX · Nasdaq · Healthcare

$2.02-30.82%

2026-10-02 close

Foghorn Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $23M. 2024 operating profit was −$103M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy